TH13812A - - Google Patents
Info
- Publication number
- TH13812A TH13812A TH9301000410A TH9301000410A TH13812A TH 13812 A TH13812 A TH 13812A TH 9301000410 A TH9301000410 A TH 9301000410A TH 9301000410 A TH9301000410 A TH 9301000410A TH 13812 A TH13812 A TH 13812A
- Authority
- TH
- Thailand
- Prior art keywords
- group
- atoms
- carbon
- hydrogen atom
- formula
- Prior art date
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract 30
- 125000000217 alkyl group Chemical group 0.000 claims abstract 25
- 150000001875 compounds Chemical class 0.000 claims abstract 14
- 239000000126 substance Substances 0.000 claims abstract 11
- 150000003839 salts Chemical class 0.000 claims abstract 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract 8
- 150000002148 esters Chemical class 0.000 claims abstract 5
- 125000005843 halogen group Chemical group 0.000 claims abstract 4
- 230000003115 biocidal effect Effects 0.000 claims abstract 3
- 125000006239 protecting group Chemical group 0.000 claims abstract 3
- 208000015181 infectious disease Diseases 0.000 claims abstract 2
- 230000000813 microbial effect Effects 0.000 claims abstract 2
- 125000004429 atom Chemical group 0.000 claims 22
- 125000004432 carbon atom Chemical group C* 0.000 claims 18
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 17
- 229910052799 carbon Inorganic materials 0.000 claims 17
- 125000000547 substituted alkyl group Chemical group 0.000 claims 11
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 10
- 125000003277 amino group Chemical group 0.000 claims 9
- 229910052736 halogen Inorganic materials 0.000 claims 6
- 150000002367 halogens Chemical class 0.000 claims 6
- 125000004066 1-hydroxyethyl group Chemical group [H]OC([H])([*])C([H])([H])[H] 0.000 claims 4
- 125000003342 alkenyl group Chemical group 0.000 claims 4
- 125000004093 cyano group Chemical group *C#N 0.000 claims 4
- -1 ester salts Chemical class 0.000 claims 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 3
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000004434 sulfur atom Chemical group 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 2
- 125000000278 alkyl amino alkyl group Chemical group 0.000 claims 2
- 150000001450 anions Chemical group 0.000 claims 2
- 150000002500 ions Chemical class 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- 241001302806 Helogenes Species 0.000 claims 1
- 125000003282 alkyl amino group Chemical group 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- SMDHCQAYESWHAE-UHFFFAOYSA-N benfluralin Chemical compound CCCCN(CC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O SMDHCQAYESWHAE-UHFFFAOYSA-N 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000007123 defense Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 238000006073 displacement reaction Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229940127557 pharmaceutical product Drugs 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 238000007493 shaping process Methods 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH13812A true TH13812A (enrdf_load_stackoverflow) | 1994-04-15 |
| TH10445B TH10445B (th) | 2001-05-18 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69430581D1 (de) | Verbindungen des chinolizinon-typs | |
| MX9709416A (es) | Compuesto tipo quinolizinona. | |
| OA09982A (fr) | Derives heterocycliques leur procede de production et composition pharmaceutique les contenant | |
| HUT70768A (en) | N-containing cyclic compounds, pharmaceutical compositions containing them, and process for producing them | |
| DK0937048T3 (da) | Heterocykliske derivater, der inhiberer faktor Xa | |
| MY129970A (en) | Hypolipidaemic compounds | |
| DE69624437D1 (de) | 4,6-diarylpyrimidin-derivate und deren salze | |
| HUT57772A (en) | Process for producing physostigmine analogs and pharmaceutical compositions comprising such compounds | |
| HUT61555A (en) | Process for producing 2,8-dioxa-bicyclo/3.2.1/octane derivatives and pharmaceutical compositions comprising same | |
| PT849269E (pt) | Vinil-pirrolidina cefalosporinas com substituintes basicos | |
| GB9113628D0 (en) | Heterocyclic derivatives | |
| NZ503822A (en) | 2-halo-6-O-substituted erythromycin derivatives, a process for their preparation and pharmaceuticals thereof, useful for treating bacterial infections | |
| BR1100983A (pt) | Novos compostos derivados de bezimidazol, processo de preparação dos compostos, composições farmacêuticas, e, utilização dos derivados | |
| ES474215A1 (es) | Procedimiento para la preparacion de derivados imidazolile- tiloxialcoxilicos y sus analogos con agrupacion tio | |
| NZ314003A (en) | Medicaments for treating osteoporosis containing thiazolidine compounds | |
| SE8501421L (sv) | 1-(hydroximetyl)-1,6,7,11b-tetrahydro-2h,4h-(1,3)-oxazino- eller -tiazino(4,3-a)isokinolinderivat, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem | |
| FI970427A0 (fi) | Menetelmä mikrobinvastaisten yhdisteiden valmistamiseksi | |
| ATE195122T1 (de) | Verbindungen vom chinolizinon-typ | |
| HU9202319D0 (en) | Method for producing substituted dibenz(b,f)(1,4)oxazepine-11(10h)-ones and pharmaceutical preparatives containing said compounds as active agent | |
| ES2110977T3 (es) | Espiro-isoquinolein-pirrolidinas y analogos de las mismas, utiles como inhibidores de la aldosa-reductasa. | |
| ATE287874T1 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
| AR011148A1 (es) | Compuesto de hexahidro-1h-pirrolizina con sustitucion de 7a-heterociclo, composicion farmaceutica que los comprenden y uso de dichos compuestos parala manufactura de un medicamento util en el control de la transmision sinaptica quimica | |
| ES2091489T3 (es) | Derivados de imidazol y composiciones farmaceuticas que los contienen. | |
| DE68917772D1 (de) | 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen. | |
| GB9715895D0 (en) | Heterocyclic compounds |